---
source_pdf: "https://drive.google.com/file/d/1BkOP0hC5JbPaPbzh17pVlxILoOqcFkyb/view"
drive_folder: "Research"
type: research

ingested: 2025-12-28
original_filename: "Mavida Health.pdf"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1BkOP0hC5JbPaPbzh17pVlxILoOqcFkyb/view)

## Slide 1: MAVIDA health

MAVIDA health
Supporting mental health from preconception to postpartum

## Slide 2: Heavy toll of maternal mental health conditions

**Heavy toll of maternal mental health conditions**

*   #1 complication of childbirth
*   Leading cause of pregnancy-related death
*   Adverse mother + child health implications, costing $18B*
*   Current solutions are limited, low quality and expensive

* from conception to 5 years postpartum

## Slide 3: The MAVIDA health solution

**The MAVIDA health solution:**
Comprehensive, digital mental health care for
every stage of the maternity journey

*   PHYSICIAN-led, perinatal mental health care via a
    virtual platform providing scalable, evidence-based
    treatments
*   CONTENT and educational tools about the fertility
    journey, pregnancy, parenting and mental health from
    experts and peers
*   COMMUNITY that provides connection and support
    through curated, expert-moderated forums

## Slide 4: The US market is large and underestimated

**The US market is large and underestimated**

| Category                  | Value   | Details                                                        |
| :------------------------ | :------ | :------------------------------------------------------------- |
| **Trying to Conceive**    | $15B    | ~ 7M people have trouble conceiving each year                |
| **Pregnancy Loss**        | $4B     | ~ 1M pregnancies end in miscarriage and stillbirth           |
|                           |         | ~ 1M pregnancies are terminated                                |
| **Pregnancy + Postpartum** | $72B*   | ~ 6M pregnancies per year <br> ~4M live births per year      |

* Includes associated medical costs three years after childbirth

## Slide 5: Comparing the competition

**Comparing the competition**

| Feature             | Poppy Seed | Expectful | Peanut | Tia | Academic Programs | MAVIDA |
| :------------------ | :--------- | :-------- | :----- | :-- | :---------------- | :----- |
| Therapy             |            |           |        |     | ✓                 | ✓      |
| Prescribing         |            |           |        | ✓   | ✓                 | ✓      |
| Non-clinical support | ✓          | ✓         |        |     |                   | ✓      |
| Education           |            | ✓         |        |     |                   | ✓      |
| Community           |            |           | ✓      |     |                   | ✓      |
| Tech-enabled        | ✓          | ✓         | ✓      | ✓   |                   | ✓      |
| Maternity-focused   | ✓          | ✓         | ✓      |     | ✓                 | ✓      |

## Slide 6: Better treatment starts with modernized screening

**Better treatment starts with modernized screening**

**Status Quo**
*   Pen and paper
*   Non-standardized screening
*   Screening without results
*   HEDIS screening + referral compliance <20%

**MAVIDA**
*   QR code with an easy-to-use digital alternative
*   Validated depression + anxiety screening
*   Immediate recommendations + linkage to treatment
*   Improved HEDIS scores, actionable screener results

## Slide 7: Building blocks of the MAVIDA health approach

**Building blocks of the MAVIDA health approach**

*(From top to bottom, increasing symptom severity, decreasing visit frequency)*

| Treatment Component                     | Applies To      | Frequency   |
| :-------------------------------------- | :-------------- | :---------- |
| Medication management                   | All patients    | As needed   |
| Family / couples therapy                | All patients    | As needed   |
| Individual therapy                      |                 |             |
| Group therapy                           |                 |             |
| Health coaching                         |                 |             |
| Educational content, tracking + peer support |                 |             |

**Symptom severity** (arrow pointing up)
**Visit frequency** (arrow pointing down)

## Slide 8: Leveraging our established relationships to go-to-market

**Leveraging our established relationships to go-to-market**

**TRADITIONAL CHANNELS**
*   **Community providers**
    OBGYNs, Pediatricians, Therapists
*   **Medical systems**
    NY Presbyterian, Cedars Sinai, Providence Health System
*   **Insurers**
    Oscar, UHC
*   **Self-insured employers**
    L'Oreal

**TRUSTED DTC BRANDS**
*   **Women's health platforms**
    Kindbody, Origin
*   **Maternity brands**
    ByHeart, Elvie, Hatch
*   **Wellness brands**
    Perelel, Headspace
*   **DTC Pharmacy**
    Capsule

## Slide 9: Building the MAVIDA health value story

**Building the MAVIDA health value story**

`Establishing demand` -> `Risk-sharing` -> `Value-based care`
`Collecting outcomes` (underneath all)

|                | Establishing demand           | Risk-sharing                  | Value-based care                   |
| :------------- | :---------------------------- | :---------------------------- | :--------------------------------- |
| **Model**      | Membership + Fee for service  | Bundled case rates            | Milestone payments                 |
| **Channels**   | Direct to consumer            | Self-insured employers        | Public and private insurers        |
|                | In-network with select payers | Private insurers              | Employers                          |
|                | Early provider partners       | Direct to consumer            | Direct to consumer                 |

## Slide 10: MAVIDA health route to profitability

**MAVIDA health route to profitability**

**Chart Data: MAVIDA health Revenue, Cost, and Profit ($M) by Quarter (2023-2025)**

| Quarter | Revenue ($M) | Cost ($M) | Profit ($M) |
|:--------|:-------------|:----------|:------------|
| 2023 Q1 | ~0.1         | ~0.4      | ~-0.3       |
| 2023 Q2 | ~0.15        | ~0.45     | ~-0.3       |
| 2023 Q3 | ~0.2         | ~0.5      | ~-0.3       |
| 2023 Q4 | ~0.3         | ~0.55     | ~-0.25      |
| 2024 Q1 | ~0.4         | ~0.6      | ~-0.2       |
| 2024 Q2 | ~0.55        | ~0.7      | ~-0.15      |
| 2024 Q3 | ~0.7         | ~0.75     | ~-0.05      |
| 2024 Q4 | ~0.9         | ~0.8      | ~0.1        |
| 2025 Q1 | ~0.95        | ~0.85     | ~0.1        |
| 2025 Q2 | ~1.1         | ~0.9      | ~0.2        |
| 2025 Q3 | ~1.2         | ~0.95     | ~0.25       |
| 2025 Q4 | ~1.3         | ~1.0      | ~0.3        |

*Key milestones on timeline:*
*   2023 Q1-Q2: Build and test.
*   2023 Q3: Postpartum launch
*   2024 Q1: Pregnancy launch
*   2024 Q2: Pregnancy loss launch
*   2024 Q3: Trying to conceive launch

*   Annual membership fee of **$199** covers access to platform, educational content and community forums
*   For patients requiring clinical care, additional weekly fees of **$275-375** will vary based on severity level and reflect fee for service reimbursement rates
*   Member length of stay will vary by stage and severity (3-12 months)
    *   Members with more acute needs will be empowered to step down their care over time
*   Profitability may be reached earlier with bundled/value-based case rates

## Slide 11: The MAVIDA team

**The MAVIDA team**

**Sarah Oreck MD MS**
Co-founder + CEO
Perinatal Psychiatrist, Health Tech Advisor
Latina + Mother
*   COLUMBIA UNIVERSITY DEPARTMENT OF PSYCHIATRY
*   Perelel
*   Cedars Sinai
*   Providence
*   Origin.

**Emma Sugerman MBA**
Co-founder + COO
Digital Health Strategy
Mother
*   headspace
*   Optum
*   charlie health
*   Origin.
*   LifeStance HEALTH

**Megan Jones Bell**
Advisor
Clinical Director, Google
Mother
*   Google
*   headspace
*   lantern

**Duncan Greenberg**
Advisor
VP of Product, Oscar
Father
*   oscar
*   signpost
*   Forbes

**Phyllis Lantos**
Advisor
Former CFO New York Presbyterian Hospital
Mother + Grandmother
*   NewYork-Presbyterian
*   Montefiore
*   Yale SCHOOL OF MEDICINE

## Slide 12: MAVIDA health in the near term

**MAVIDA health in the near term**

*   Initial capital ask of **$1.5M** will fund hiring core team, building MVP and pursuing early channel partnerships
*   Enable early data collection in pursuit of payer relationships and outcomes-based model
*   Launch Markets: California + New York followed by the other 8 states with mandated screening

## Slide 13: Mothers need MAVIDA

**Mothers need MAVIDA**

From dozens of patient interviews and thousands of patient encounters,
we have heard repeatedly that women on their path to parenthood...

*   need specialized mental health support that considers their journey
*   are unanimously willing to pay for these services
*   are desperately seeking community and answers, 75k+ of whom follow @sarahoreckmd

## Slide 14: The MAVIDA health vision

**The MAVIDA health vision**

Specialized mental health care to take you from your first period through menopause

*(Timeline of a woman's reproductive health journey)*
*   Puberty
*   PMDD, PCOS, Endometriosis, Pelvic Pain
*   Fertility, Pregnancy, Postpartum
*   Perimenopause, Menopause

## Slide 15: APPENDIX

**APPENDIX**

## Slide 16: Why now?

**Why now?**

**The motherhood journey is more costly than ever**

*   Maternal morbidity = **$32B** from conception to child's 5th birthday
*   Inadequate paid parental leave = **$28.5B** in lost national income
*   Unaffordable childcare = **$57B** in lost earnings and productivity
*   Formula shortages = price increases of **11%**
*   Abortion restrictions = **$105B**

## Slide 17: Current treatment is inadequate

**Current treatment is inadequate**

*   **1 in 5** women will develop mood and anxiety disorders*
*   **70%** UNDIAGNOSED
*   **85%** of diagnosed go UNTREATED
*   **93%** DO NOT receive effective treatment
*   Day programs can run up to **$1,200/day**

* during pregnancy and up to five years after childbirth

## Slide 18: The MAVIDA health experience

**The MAVIDA health experience**

*   Patient acquisition through standardized screening
*   Referral to MAVIDA and educational resources
*   Comprehensive member assessment with a MAVIDA clinician
*   Triage member to appropriate level of care
*   Clinical and supportive programming determined by severity of symptoms (e.g. med mgmt, therapy, coaching)
*   Education, community support and family resources available between appointments

## Slide 19: MAVIDA health support between sessions

**MAVIDA health support between sessions**

**Education**
*   Content library with short, easily digestible videos
*   Guided activities for independent skill-building
*   Actionable tips + lifestyle modifications

**Community**
*   Expert-moderated group chats based on member's stage in the maternity journey

**Tracking**
*   Mood
*   Sleep
*   Activity

## Slide 20: MAVIDA addresses provider shortages

**MAVIDA addresses provider shortages**

*   Hybrid clinical + community model including prescribers, therapists and health coaches
*   Enhancing our tech base to increase clinical staff efficiency
*   Perinatal training modules for all staff
*   Educational content and technology that will aid in skill-building between clinical sessions

## Slide 21: $2.5B invested in 2021 in women's health, but gaps still remain

**$2.5B invested in 2021 in women's health, but gaps still remain**

**Investment in Women's Health Categories (2021)**

*   Primary care: $668M (Companies: ro, frida, Tia, MAVEN, CARROT, Modern Fertility, pomelo care)
*   Fertility: $345M (Companies: MAVEN, CARROT, Modern Fertility, kindbody)
*   Pregnancy + postpartum: $316M (Companies: Flo, Tia, MAVEN, kindbody, Hey Jane)
*   Menopause: $88M (Companies: EVERNOW, ELEKTRA HEALTH)
*   Sexual + reproductive care: $52M (Companies: ro, Tia, Hey Jane)
*   Menstrual care: $5M (Companies: Flo, Tia)

**Mental Health: $3.1B** (MAVIDA health is positioned within this area, with an implied connection to pregnancy/postpartum and fertility)